BVF PARTNERS L P/IL Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BVF PARTNERS L P/IL.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).

Latest Insider Trading Transactions of BVF PARTNERS L P/IL

Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA

Page: < prev 1 2 3 4

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.00	2,109,280	6,327,840	2,109,280	0 to 2.1 M
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.00	2,109,280	6,327,840	2,109,280	0 to 2.1 M
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.00	3,041,120	9,123,360	3,041,120	0 to 3 M
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.00	3,041,120	9,123,360	3,041,120	0 to 3 M
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Sell	D	0.00	1,487,294	0	596,357	2.1 M to 596.4 K (-71.38 %)
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Sell	D	0.00	1,487,294	0	596,357	2.1 M to 596.4 K (-71.38 %)
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Sell	D	0.00	651,074	0	0	651.1 K to 0 (-100.00 %)
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Sell	D	0.00	651,074	0	0	651.1 K to 0 (-100.00 %)
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Sell	D	0.00	2,295,083	0	0	2.3 M to 0 (-100.00 %)
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Sell	D	0.00	2,295,083	0	0	2.3 M to 0 (-100.00 %)
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Sell	D	0.00	3,566,549	0	0	3.6 M to 0 (-100.00 %)
Feb 12 2018	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Sell	D	0.00	3,566,549	0	0	3.6 M to 0 (-100.00 %)
Dec 21 2017	CNCE	CONCERT PHARMACEUT ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	26.65	169,292	4,511,632	122,496	291.8 K to 122.5 K (-58.02 %)
Dec 21 2017	CNCE	CONCERT PHARMACEUT ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	26.65	445,615	11,875,640	632,642	1.1 M to 632.6 K (-41.33 %)
Dec 21 2017	CNCE	CONCERT PHARMACEUT ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	26.65	667,949	17,800,841	951,300	1.6 M to 951.3 K (-41.25 %)
Oct 23 2017	CNCE	CONCERT PHARMACEUT ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	15.84	34,632	548,484	291,788	257.2 K to 291.8 K (+13.47 %)
Oct 23 2017	CNCE	CONCERT PHARMACEUT ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	15.84	135,206	2,141,325	1,078,257	943.1 K to 1.1 M (+14.34 %)
Oct 23 2017	CNCE	CONCERT PHARMACEUT ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	15.84	162,078	2,566,910	1,619,249	1.5 M to 1.6 M (+11.12 %)
Oct 05 2017	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.28	63,042	80,946	790,583	727.5 K to 790.6 K (+8.67 %)
Oct 05 2017	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.28	235,326	302,159	2,968,487	2.7 M to 3 M (+8.61 %)
Oct 05 2017	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.28	355,081	455,924	4,509,785	4.2 M to 4.5 M (+8.55 %)
Oct 05 2017	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.24	28,918	35,714	727,541	698.6 K to 727.5 K (+4.14 %)
Oct 05 2017	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.24	394,078	486,686	2,733,161	2.3 M to 2.7 M (+16.85 %)
Oct 05 2017	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.24	523,601	646,647	4,154,704	3.6 M to 4.2 M (+14.42 %)
Aug 16 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.41	7,429	17,920	1,077,694	1.1 M to 1.1 M (+0.69 %)
Aug 16 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.41	11,429	27,569	1,674,468	1.7 M to 1.7 M (+0.69 %)
Aug 16 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.70	13,337	36,058	1,070,265	1.1 M to 1.1 M (+1.26 %)
Aug 16 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.70	28,007	75,720	1,663,039	1.6 M to 1.7 M (+1.71 %)
Jul 18 2017	CAPS	Capstone Therapeut ...	BVF PARTNERS L P/IL		Sell	S	0.06	105,713	6,343	890,487	996.2 K to 890.5 K (-10.61 %)
Jul 18 2017	CAPS	Capstone Therapeut ...	BVF PARTNERS L P/IL		Sell	S	0.06	242,236	14,534	1,377,652	1.6 M to 1.4 M (-14.95 %)
Jul 18 2017	CAPS	Capstone Therapeut ...	BVF PARTNERS L P/IL		Sell	S	0.06	3,993,637	239,618	0	4 M to 0 (-100.00 %)
Jun 29 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	8,496	33,984	297,464	289 K to 297.5 K (+2.94 %)
Jun 29 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	30,170	120,680	1,056,928	1 M to 1.1 M (+2.94 %)
Jun 29 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	46,795	187,180	1,635,032	1.6 M to 1.6 M (+2.95 %)
Jun 23 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	854	3,416	288,968	288.1 K to 289 K (+0.30 %)
Jun 23 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	2,884	11,536	1,026,758	1 M to 1 M (+0.28 %)
Jun 23 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	4,525	18,100	1,588,237	1.6 M to 1.6 M (+0.29 %)
Jun 23 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	1,362	5,448	288,114	286.8 K to 288.1 K (+0.47 %)
Jun 23 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	4,406	17,624	1,023,874	1 M to 1 M (+0.43 %)
Jun 23 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	4.00	6,380	25,520	1,583,712	1.6 M to 1.6 M (+0.40 %)
Jun 22 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	1,715	3,859	201,811	200.1 K to 201.8 K (+0.86 %)
Jun 22 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	6,359	14,308	717,089	710.7 K to 717.1 K (+0.89 %)
Jun 22 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	9,732	21,897	1,109,258	1.1 M to 1.1 M (+0.89 %)
Jun 19 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.85	357	1,374	286,752	286.4 K to 286.8 K (+0.12 %)
Jun 19 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.85	1,271	4,893	1,019,468	1 M to 1 M (+0.12 %)
Jun 19 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.85	1,967	7,573	1,577,332	1.6 M to 1.6 M (+0.12 %)
Jun 19 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.85	1,064	4,096	286,395	285.3 K to 286.4 K (+0.37 %)
Jun 19 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.85	3,873	14,911	1,018,197	1 M to 1 M (+0.38 %)
Jun 19 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.85	6,097	23,473	1,575,365	1.6 M to 1.6 M (+0.39 %)
Jun 19 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.84	1,160	4,451	285,331	284.2 K to 285.3 K (+0.41 %)
Jun 19 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.84	3,845	14,753	1,014,324	1 M to 1 M (+0.38 %)
Jun 19 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.84	6,774	25,992	1,569,268	1.6 M to 1.6 M (+0.43 %)
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	C	0.00	536	0	49
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	C	0.00	513	0	48
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	C	0.00	2,115	0	197
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	C	0.00	3,011	0	281
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	0.00	585	0	585
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	0.00	561	0	561
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	0.00	2,312	0	2,312
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Option Exercise	P	0.00	3,292	0	3,292
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	C	0.00	357,333	0	2,083,651	1.7 M to 2.1 M (+20.70 %)
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	C	0.00	342,000	0	651,074	309.1 K to 651.1 K (+110.65 %)
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	C	0.00	1,410,000	0	2,295,083	885.1 K to 2.3 M (+159.31 %)
Jun 14 2017	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	C	0.00	2,007,333	0	3,566,549	1.6 M to 3.6 M (+128.74 %)
Jun 08 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.85	20,594	79,312	284,171	263.6 K to 284.2 K (+7.81 %)
Jun 08 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.85	73,749	284,022	1,010,479	936.7 K to 1 M (+7.87 %)
Jun 08 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.85	113,446	436,903	1,562,494	1.4 M to 1.6 M (+7.83 %)
Jun 08 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.75	913	3,424	263,577	262.7 K to 263.6 K (+0.35 %)
Jun 08 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.75	53,260	199,725	936,730	883.5 K to 936.7 K (+6.03 %)
Jun 08 2017	XENE	Xenon Pharmaceutic ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.75	96,736	362,760	1,449,048	1.4 M to 1.4 M (+7.15 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.28	3,673	8,379	200,096	196.4 K to 200.1 K (+1.87 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.28	13,046	29,762	710,730	697.7 K to 710.7 K (+1.87 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.28	20,181	46,039	1,099,526	1.1 M to 1.1 M (+1.87 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.29	3,920	8,979	196,423	192.5 K to 196.4 K (+2.04 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.29	12,624	28,917	697,684	685.1 K to 697.7 K (+1.84 %)
Jun 07 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.29	19,206	43,993	1,079,345	1.1 M to 1.1 M (+1.81 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	2,727	6,128	192,503	189.8 K to 192.5 K (+1.44 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	10,023	22,522	685,060	675 K to 685.1 K (+1.48 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.25	15,350	34,491	1,060,139	1 M to 1.1 M (+1.47 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	1,805	4,144	189,776	188 K to 189.8 K (+0.96 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	6,903	15,847	675,037	668.1 K to 675 K (+1.03 %)
Jun 01 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	10,192	23,398	1,044,789	1 M to 1 M (+0.99 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	1,124	2,585	187,971	186.8 K to 188 K (+0.60 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	4,223	9,713	668,134	663.9 K to 668.1 K (+0.64 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	6,253	14,382	1,034,597	1 M to 1 M (+0.61 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	2,909	6,690	186,847	183.9 K to 186.8 K (+1.58 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	10,541	24,242	663,911	653.4 K to 663.9 K (+1.61 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	16,436	37,800	1,028,344	1 M to 1 M (+1.62 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	5,510	12,666	183,938	178.4 K to 183.9 K (+3.09 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	6,897	15,854	653,370	646.5 K to 653.4 K (+1.07 %)
May 19 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.30	24,965	57,387	1,011,908	986.9 K to 1 M (+2.53 %)
May 11 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.34	675	1,581	178,428	177.8 K to 178.4 K (+0.38 %)
May 11 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.34	2,565	6,010	646,473	643.9 K to 646.5 K (+0.40 %)
May 11 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.34	3,794	8,889	986,943	983.1 K to 986.9 K (+0.39 %)
May 11 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.35	6,217	14,583	177,753	171.5 K to 177.8 K (+3.62 %)
May 11 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.35	22,092	51,821	643,908	621.8 K to 643.9 K (+3.55 %)
May 11 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.35	33,691	79,029	983,149	949.5 K to 983.1 K (+3.55 %)
May 11 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.29	3,929	8,989	171,536	167.6 K to 171.5 K (+2.34 %)
May 11 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.29	14,274	32,657	621,816	607.5 K to 621.8 K (+2.35 %)
May 11 2017	NVLS	Nivalis Therapeuti ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.29	21,797	49,869	949,458	927.7 K to 949.5 K (+2.35 %)
Jan 05 2017	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.34	3,234	4,333	2,339,083	2.3 M to 2.3 M (+0.14 %)
Jan 05 2017	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.34	1,145	1,534	3,631,103	3.6 M to 3.6 M (+0.03 %)
Dec 30 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.34	1,205	1,614	2,335,849	2.3 M to 2.3 M (+0.05 %)
Dec 30 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.34	2,348	3,145	3,629,958	3.6 M to 3.6 M (+0.06 %)
Dec 30 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.34	77,076	102,943	698,623	621.5 K to 698.6 K (+12.40 %)
Dec 30 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.34	260,046	347,317	2,334,644	2.1 M to 2.3 M (+12.53 %)
Dec 30 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.34	401,726	536,545	3,627,610	3.2 M to 3.6 M (+12.45 %)
Dec 20 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.35	2,244	3,040	621,547	619.3 K to 621.5 K (+0.36 %)
Dec 20 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.35	8,111	10,990	2,074,598	2.1 M to 2.1 M (+0.39 %)
Dec 20 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.35	11,646	15,779	3,225,884	3.2 M to 3.2 M (+0.36 %)
Dec 20 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.36	21,021	28,555	619,303	598.3 K to 619.3 K (+3.51 %)
Dec 20 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.36	69,041	93,785	2,066,487	2 M to 2.1 M (+3.46 %)
Dec 20 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.36	108,202	146,982	3,214,238	3.1 M to 3.2 M (+3.48 %)
Dec 20 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.28	47,812	61,199	598,282	550.5 K to 598.3 K (+8.69 %)
Dec 20 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.28	150,451	192,577	1,997,446	1.8 M to 2 M (+8.15 %)
Dec 20 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.28	236,393	302,583	3,106,036	2.9 M to 3.1 M (+8.24 %)
Dec 02 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.19	2,916	3,470	550,470	547.6 K to 550.5 K (+0.53 %)
Dec 02 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.19	18,586	22,119	1,846,995	1.8 M to 1.8 M (+1.02 %)
Dec 02 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.19	30,998	36,891	2,869,643	2.8 M to 2.9 M (+1.09 %)
Dec 02 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.18	15,161	17,958	547,554	532.4 K to 547.6 K (+2.85 %)
Dec 02 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.18	52,457	62,135	1,828,409	1.8 M to 1.8 M (+2.95 %)
Dec 02 2016	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.18	81,276	96,271	2,838,645	2.8 M to 2.8 M (+2.95 %)
Jan 11 2016	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.22	58,613	71,338	17,263,200	17.2 M to 17.3 M (+0.34 %)
Jan 11 2016	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.22	32,571	39,642	3,090,744	3.1 M to 3.1 M (+1.07 %)
Jan 11 2016	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.22	90,049	109,599	8,850,836	8.8 M to 8.9 M (+1.03 %)
Jan 11 2016	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.22	186,314	226,763	15,592,160	15.4 M to 15.6 M (+1.21 %)
Jan 11 2016	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.22	8,091	9,848	17,204,587	17.2 M to 17.2 M (+0.05 %)
Jan 11 2016	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.22	29,655	36,093	3,058,173	3 M to 3.1 M (+0.98 %)
Jan 11 2016	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.22	87,747	106,797	8,760,787	8.7 M to 8.8 M (+1.01 %)
Jan 11 2016	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	10% Owner	Buy	P	1.22	508,287	618,636	15,405,846	14.9 M to 15.4 M (+3.41 %)
Nov 05 2015	CCXI	ChemoCentryx, Inc.	BVF PARTNERS L P/IL		Sell	J	0.00	2,384,577	0	0	2.4 M to 0 (-100.00 %)
Nov 05 2015	CCXI	ChemoCentryx, Inc.	BVF PARTNERS L P/IL		Sell	S	7.00	287,000	2,009,057	2,384,577	2.7 M to 2.4 M (-10.74 %)
Nov 05 2015	CCXI	ChemoCentryx, Inc.	BVF PARTNERS L P/IL		Sell	S	6.98	73,000	509,343	2,671,577	2.7 M to 2.7 M (-2.66 %)
Nov 02 2015	CCXI	ChemoCentryx, Inc.	BVF PARTNERS L P/IL	10% Owner	Sell	S	6.97	50,000	348,515	2,744,577	2.8 M to 2.7 M (-1.79 %)
Jun 11 2015	CCXI	ChemoCentryx, Inc.	BVF PARTNERS L P/IL	10% Owner	Sell	S	9.01	31,000	279,229	2,794,577	2.8 M to 2.8 M (-1.10 %)
Jun 11 2015	CCXI	ChemoCentryx, Inc.	BVF PARTNERS L P/IL	10% Owner	Sell	S	9.00	924,700	8,322,392	2,825,577	3.8 M to 2.8 M (-24.66 %)

Page: < prev 1 2 3 4